Free thyroxine, cognitive decline and depression in Alzheimer's disease

Neuroendocrinology Letters

Volumn 27, Issue 4, 2006, Pages 535-537

  Stuerenburg, Hans Joerg ^a,b   Arlt, Soenke ^b   Mueller Thomsen, Tomas ^b,c  

^a MEDIAN Kliniken GmbH   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c Psychiatric Clinic Haecklingen   (Germany)

Author keywords

Alzheimer's disease; Cognitive function; Minimental status examination; Neurotoxicity; Plasma free thyroxine; Subclinical hyperthyroidism

Indexed keywords

LIOTHYRONINE; THYROTROPIN; THYROXINE;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION COEFFICIENT; DEPRESSION; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; GERIATRIC DEPRESSION SCALE; HORMONE DETERMINATION; HUMAN; LIOTHYRONINE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; OUTPATIENT; SCORING SYSTEM; STATISTICAL SIGNIFICANCE; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

EID: 33845982611     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Davis JD, Stern RA, Flashman LA., Cognitive and neuropsychiatric aspects of subclinical hypothyroidism: significance in the elderly, Curr Psychiatry Rep 2003; 5: 384-390.
2. Small GW, Matsuyama SS, Komanduri R, Kumar V, Jarvik LF. Thyroid disease in patients with dementia of the Alzheimer type, J Am Geriatr Soc 1985; 33: 538-539.
3. Thomas DR, Hailwood R, Harris B, Williams PA, Scanlon MF. John R. Thyroid status in senile dementia of the Alzheimer type (SDAT), Acta Psychiatr Scand 1987; 76: 158-163.
4. Lopez O, Huff FJ, Martinez AJ, Bedetti CD. Prevalence of thyroid abnormalities is not increased in Alzheimer's disease, Neurobiol Aging 1989; 10: 247-251.
5. Kalmijn S, Mehta KM, Pols HA, Hofman A, Drexhage HA, Breteler MM. Subclinical hyperthyroidism and the risk of dementia. The Rotterdam study, Clin Endocrinol (Oxf) 2000; 53: 733-737.
6. Dobert N, Hamscho N, Menzel C, Peters J, Frolich L, Tsolakis A, Zaplatnikov K, Kratzsch T, Diener J, Maurer K, Grunwald F. Subclinical: hyperthyroidism in dementia and correlation of the metabolic index in FDG-PET, Acta Med Austriaca 2003; 30:130-133.
7. van Osch LA, Hogervorst E, Combrinck M, Smith AD. Low thyroid-stimulating hormone as an independent risk factor for Alzheimer disease, Neurology 2004; 62:1967-1971.
8. Stern RA, Davis JD, Rogers BL, Smith KE, Harrington CJ, Ott BR, Jackson IM, Prange AJ Jr. Preliminary study of the relationship between thyroid status and cognitive and neuropsychiatric functioning in euthyroid patients with Alzheimer dementia, Cogn Behav Neurol 2004; 17: 219-223.
9. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician, J Psychiatr Res 1975; 12: 189-198.
10. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM, Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease, Neurology 1984; 34: 939-944.
11. Stuerenburg HJ, Mueller-Thomsen T. Methner A. Vitamin B 12 plasma levels in Alzheimer's disease. Neuroendocrinology Lett 2004 Jun;25(3):176-7.
12. Stuerenburg HJ, Ganzer S, Muller-Thomsen T. 5-hydroxyindoleacetic acid and homovanillic acid concentrations in cerebrospinal fluid in patients with Alzheimer's disease, depression and mild cognitive impairment. Neuroendocrinology Lett 2004 Dec; 25(6):435-7.
13. Stuerenburg HJ, Ganzer S, Arlt S, Muller-Thomsen T. The influence of smoking on plasma folate and lipoproteins in Alzheimer disease, mild cognitive impairment and depression. Neuro Endocrinol Lett 2005 Jun; 26(3):261-3.
14. Stuerenburg HJ, Ganzer S, Mueller-Thomsen. Plasma beta-carotene in Alzheimer's disease. Association with cerebrospinal fluid beta-amyloid 1-40, beta-amyloid 1-42 and total Tau. Neuro Endocrinol Lett 2005 Dec; 26(6):696-8.
15. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res 1990; 31: 545-548.
16. Hosoda R, Nakayama K, Kato-Negishi M, Kawahara M, Muramoto K, Kuroda Y. Thyroid hormone enhances the formation of synapses between cultured neurons of rat cerebral cortex, Cell Mol Neurobiol 2003; 23: 895-906.
17. Calza L, Fernandez M, Giuliani A, D'Intino G, Pirondi S, Sivilia S, Paradisi M, Desordi N, Giardino L. Thyroid hormone and remyelination in adult central nervous system: a lesson from an inflammatory-demyelinating disease, Brain Res Brain Res Rev 2005; 48: 339-346.
18. Vara H, Martinez B, Santos A, Colino A. Thyroid hormone regulates neurotransmitter release in neonatal rat hippocampus, Neuroscience 2002; 110: 19-28.